These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7301686)

  • 1. A case of prenylamine toxicity showing the torsade de pointes phenomenon in sinus rhythm?
    Meanock CI; Noble MI
    Postgrad Med J; 1981 Jun; 57(668):381-4. PubMed ID: 7301686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible female preponderance in prenylamine-induced 'torsade de pointes' tachycardia. Short communication.
    Abinader EG; Shahar J
    Cardiology; 1983; 70(1):37-40. PubMed ID: 6850685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of prenylamine syncope (torsades de pointes)].
    Oda E; Takeda K; Ohno T; Nagai T; Shibuya T; Aizawa Y; Arai Y; Ozawa T; Shibata A
    Kokyu To Junkan; 1985 Mar; 33(3):453-8. PubMed ID: 4012076
    [No Abstract]   [Full Text] [Related]  

  • 4. Torsade de pointes due to prenylamine controlled by lignocaine.
    Tamari I; Rabinowitz B; Neufeld HN
    Eur Heart J; 1982 Aug; 3(4):389-92. PubMed ID: 7128627
    [No Abstract]   [Full Text] [Related]  

  • 5. Torsade de pointes with prenylamine: do we still need the drug?
    Fraser AG; Ikram S
    Lancet; 1986 Sep; 2(8506):572. PubMed ID: 2875301
    [No Abstract]   [Full Text] [Related]  

  • 6. Prenylamine-induced ventricular arrhythmias and syncopal attacks with Q-T prolongation. Report of a case and comment on therapeutic use of lignocaine.
    Riccioni N; Bartolomei C; Soldani S
    Cardiology; 1980; 66(4):199-203. PubMed ID: 7448836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic mechanisms underlying prenylamine-induced 'torsade de pointes': differences between prenylamine and fendiline due to basic actions of the isomers.
    Bayer R; Schwarzmaier J; Pernice R
    Curr Med Res Opin; 1988; 11(4):254-72. PubMed ID: 3063437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prolonged QT interval and "torsades de pointes" after therapy with prenylamin (Segontin) (author's transl)].
    Burri C; Ajdacic K; Michot F
    Schweiz Rundsch Med Prax; 1981 Apr; 70(16):717-20. PubMed ID: 7335622
    [No Abstract]   [Full Text] [Related]  

  • 10. "Torsade de pointes" tachycardia. Re-entry or focal activity?
    D'Alnoncourt CN; Zierhut W; Blüderitz B
    Br Heart J; 1982 Sep; 48(3):213-6. PubMed ID: 7104111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular tachycardia precipitated by sodium iothalamate (Conray 420) injection during prenylamine treatment: a predictable adverse drug interaction.
    Duncan JS; Ramsay LE
    Postgrad Med J; 1985 May; 61(715):415-7. PubMed ID: 4022877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide.
    Commerford PJ; Beck W
    S Afr Med J; 1980 Sep; 58(11):447-8. PubMed ID: 7404173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinidine-induced torsade de pointes suppressed by paroxysmal atrial fibrillation.
    Maisuls E; Lorber A
    Int J Cardiol; 1987 Sep; 16(3):315-7. PubMed ID: 3654030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prolonged Q-T interval, syncope and prenylamine].
    Fazzini PF; Marchi F; Pucci P
    G Ital Cardiol; 1973; 3(2):233-9. PubMed ID: 4123358
    [No Abstract]   [Full Text] [Related]  

  • 15. [Case of a "torsade de pointes" ventricular tachycardia].
    Szela S; Pater W; Małycha R
    Wiad Lek; 1982 Jun; 35(6):433-5. PubMed ID: 7123932
    [No Abstract]   [Full Text] [Related]  

  • 16. Prenylamine induced torsade de pointes.
    Kadiwar RM; MacMahon B
    Ir Med J; 1990 Dec; 83(4):163. PubMed ID: 2081677
    [No Abstract]   [Full Text] [Related]  

  • 17. [Torsade de pointes caused by tricyclic antidepressive agents. Description of a clinical case].
    Casazza F; Fiorista F; Rustici A; Brambilla G
    G Ital Cardiol; 1986 Dec; 16(12):1058-61. PubMed ID: 3556944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of the "long Q-T and peak-torsion syncope" syndrome caused by prenylamine].
    Aloisi B; Stuto A; Mossuti E; Brancati BM
    Minerva Cardioangiol; 1978 Oct; 26(10):687-92. PubMed ID: 750945
    [No Abstract]   [Full Text] [Related]  

  • 19. Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations?
    Surawicz B
    J Am Coll Cardiol; 1989 Jul; 14(1):172-84. PubMed ID: 2661626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenylamine-induced ventricular tachycardia and syncope controlled by ventricular pacing.
    Grenadier E; Keidar S; Alpan G; Marmor A; Palant A
    Br Heart J; 1980 Sep; 44(3):330-4. PubMed ID: 7426190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.